Neurocrine Biosciences Acquires Soleno Therapeutics in $2.9 Billion Deal
🎧 Listen:By Nicholas G. Miller | April 06, 2026Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 BillionNeurocrine Biosciences will acquire ...
🎧 Listen:By Nicholas G. Miller | April 06, 2026Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 BillionNeurocrine Biosciences will acquire ...
🎧 Listen:By The Editorial Board | April 04, 2026Healthcare Sector Sees 38 Companies Face Decreased Q1 Earnings EstimatesThe healthcare sector ...
🎧 Listen:By The Editorial Board | April 02, 2026J.P. Morgan Anticipates $13.56 Billion in Novartis's Q1 Performance Despite Headwinds J.P. ...
🎧 Listen:By Peter Loftus | April 01, 2026ELI LILLY— Eli Lilly's New Weight-Loss Pill Approved, Sparking Fierce Market Battle with ...
🎧 Listen:By Xavier Martinez | March 31, 2026NEW YORK— Pharmaceutical Deal Activity Drops Below $10 Billion ThresholdBig drugmakers are taking ...
🎧 Listen:By The Editorial Board | March 11, 2026FDA Policy Shift May Expand Drug Pipelines with Single Study ApprovalNew FDA ...